Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Responsiveness to Change of 5-point MRC scale, Endurance and Functional Evaluation for Assessing Myositis in Daily Clinical Practice.

Landon-Cardinal O, Devilliers H, Chavarot N, Mariampillai K, Rigolet A, Hervier B, Allenbach Y, Benveniste O.

J Neuromuscul Dis. 2019;6(1):99-107. doi: 10.3233/JND-180358.

PMID:
30714969
2.

Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy.

Landon-Cardinal O, Allenbach Y, Soulages A, Rigolet A, Hervier B, Champtiaux N, Monzani Q, Solé G, Benveniste O.

J Rheumatol. 2018 Dec 15. pii: jrheum.171495. doi: 10.3899/jrheum.171495. [Epub ahead of print]

PMID:
30554155
3.

Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping.

Huber AT, Bravetti M, Lamy J, Bacoyannis T, Roux C, de Cesare A, Rigolet A, Benveniste O, Allenbach Y, Kerneis M, Cluzel P, Kachenoura N, Redheuil A.

J Cardiovasc Magn Reson. 2018 Feb 12;20(1):11. doi: 10.1186/s12968-018-0430-6.

4.

Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.

Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W.

Neurology. 2018 Feb 6;90(6):e507-e517. doi: 10.1212/WNL.0000000000004923. Epub 2018 Jan 12.

PMID:
29330311
5.

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C, Renou F, Pozdzik A, Labauge P, Palat S, Berthelot JM, Pennaforte JL, Wynckel A, Lebas C, Le Gouellec N, Quémeneur T, Dahan K, Carbonnel F, Leroux G, Perlat A, Mathian A, Cacoub P, Hachulla E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N.

PLoS One. 2017 Sep 15;12(9):e0183844. doi: 10.1371/journal.pone.0183844. eCollection 2017.

6.

Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.

Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E, Saadoun D, Audia S, Rigolet A, Terrier B, Perlat A, Guillaud C, Renou F, Bernit E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N.

Medicine (Baltimore). 2017 Mar;96(10):e6205. doi: 10.1097/MD.0000000000006205.

7.

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

Allenbach Y, Keraen J, Bouvier AM, Jooste V, Champtiaux N, Hervier B, Schoindre Y, Rigolet A, Gilardin L, Musset L, Charuel JL, Boyer O, Jouen F, Drouot L, Martinet J, Stojkovic T, Eymard B, Laforêt P, Behin A, Salort-Campana E, Fain O, Meyer A, Schleinitz N, Mariampillai K, Grados A, Benveniste O.

Brain. 2016 Aug;139(Pt 8):2131-5. doi: 10.1093/brain/aww054. Epub 2016 Apr 17.

PMID:
27086869
8.

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network.

Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, Bienvenu B, Abad S, Rigolet A, Deroux A, Sene D, Perlat A, Marie I, Feurer E, Hachulla E, Fain O, Clavel G, Riviere S, Bouche PA, Gueudry J, Pugnet G, Le Hoang P, Resche Rigon M, Cacoub P, Bodaghi B, Saadoun D; French Uveitis Network.

Arthritis Rheumatol. 2016 Jun;68(6):1522-30. doi: 10.1002/art.39667.

9.

Life-Threatening Hypercalcemia Revealing Diffuse and Isolated Acute Sarcoid-Like Myositis: A New Entity? (A Case-Series).

Mageau A, Rigolet A, Benali K, Chauchard M, Ladjeroud S, Mahe I, Maisonobe T, Chauveheid MP, Papo T, Sacre K.

Medicine (Baltimore). 2016 Mar;95(10):e3089. doi: 10.1097/MD.0000000000003089. Review.

10.

Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.

Allenbach Y, Leroux G, Suárez-Calvet X, Preusse C, Gallardo E, Hervier B, Rigolet A, Hie M, Pehl D, Limal N, Hufnagl P, Zerbe N, Meyer A, Aouizerate J, Uzunhan Y, Maisonobe T, Goebel HH, Benveniste O, Stenzel W; French Myositis Network.

Am J Pathol. 2016 Mar;186(3):691-700. doi: 10.1016/j.ajpath.2015.11.010. Epub 2016 Jan 21.

PMID:
26806087
11.

[Malakoplakia of the submandibular gland in a renal transplant patient].

Schwob E, Bouaziz JD, Saussine A, Bagot M, Dionyssopoulos A, Rigolet A.

Rev Stomatol Chir Maxillofac Chir Orale. 2015 Dec;116(6):384-7. doi: 10.1016/j.revsto.2015.09.002. Epub 2015 Nov 28. French.

PMID:
26639311
12.

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial.

Allenbach Y, Guiguet M, Rigolet A, Marie I, Hachulla E, Drouot L, Jouen F, Jacquot S, Mariampillai K, Musset L, Grenier P, Devilliers H, Hij A, Boyer O, Herson S, Benveniste O.

PLoS One. 2015 Nov 5;10(11):e0133702. doi: 10.1371/journal.pone.0133702. eCollection 2015.

13.

Severe adult dermatomyositis with unusual calcinosis.

Garel B, Barète S, Rigolet A, Le Pelletier F, Benveniste O, Hervier B.

Rheumatology (Oxford). 2015 Nov;54(11):2024. doi: 10.1093/rheumatology/kev287. Epub 2015 Aug 18. No abstract available.

PMID:
26286744
14.

Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.

Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine O, Rigolet A, Roubille C, Hachulla E, Carmoi T, Bézier M, Meignin V, Conrad M, Marie L, Kostrzewa E, Michot JM, Barete S, Taly V, Cury K, Emile JF, Amoura Z; French Histiocytoses Study Group.

Blood. 2014 Aug 14;124(7):1119-26. doi: 10.1182/blood-2013-12-543793. Epub 2014 Jun 3.

15.

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, Maisonobe T, Dubourg O, Behin A, Laforet P, Stojkovic T, Eymard B, Costedoat-Chalumeau N, Campana-Salort E, Tournadre A, Musset L, Bader-Meunier B, Kone-Paut I, Sibilia J, Servais L, Fain O, Larroche C, Diot E, Terrier B, De Paz R, Dossier A, Menard D, Morati C, Roux M, Ferrer X, Martinet J, Besnard S, Bellance R, Cacoub P, Arnaud L, Grosbois B, Herson S, Boyer O, Benveniste O; French Myositis Network.

Medicine (Baltimore). 2014 May;93(3):150-7. doi: 10.1097/MD.0000000000000028.

16.

p53 phosphorylation and TP53 copy-number alterations in chronic graft-versus-host oral lichen preceding squamous cell carcinoma.

Battistella M, Cuccuini W, Elbouchtaoui M, Leboeuf C, Plassa LF, Bouhidel F, Rigolet A, Meignin V, Socié G, Ratajczak P, Janin A.

J Invest Dermatol. 2014 Mar;134(3):864-867. doi: 10.1038/jid.2013.371. Epub 2013 Sep 4. No abstract available.

17.

Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease.

Grados A, Ebbo M, Boucraut J, Vély F, Aucouturier P, Rigolet A, Terrier B, Saadoun D, Ghillani-Dalbin P, Costedoat-Chalumeau N, Harlé JR, Schleinitz N.

Int J Rheumatol. 2013;2013:426759. doi: 10.1155/2013/426759. Epub 2013 Jun 26.

18.

[Antisynthetase syndrome and lung carcinoma: a fortuitous association?].

Courties A, Lidove O, Maisonobe T, Rigolet A, Hermet A, Girard P, Ziza JM.

Rev Med Interne. 2014 Apr;35(4):271-3. doi: 10.1016/j.revmed.2013.04.012. Epub 2013 May 30. French.

PMID:
23726930
19.

Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases.

Droz N, Gilardin L, Cacoub P, Berenbaum F, Wendling D, Godeau B, Piette AM, Dernis E, Ebbo M, Fautrel B, Le Guenno G, Mekinian A, Bernard-Chabert B, Costedoat-Chalumeau N, Descloux E, Michot JM, Radenne S, Rigolet A, Rivière S, Yvin JL, Thibault V, Thabut D, Pol S, Guillevin L, Mouthon L, Terrier B.

Arthritis Care Res (Hoboken). 2013 Sep;65(9):1504-14. doi: 10.1002/acr.21990. Review.

20.

Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.

Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, Costedoat-Chalumeau N, Allenbach Y, Hervier B, Dubourg O, Maisonobe T, Charuel JL, Behin A, Herson S, Amoura Z, Grenier P, Benveniste O.

J Rheumatol. 2012 Sep;39(9):1835-9. doi: 10.3899/jrheum.111604. Epub 2012 Aug 1.

PMID:
22859355

Supplemental Content

Loading ...
Support Center